Logo

    New Uses for Old Drugs: Insights on a Treatment Option for OIC

    enMarch 07, 2023
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    Host: Charles Turck, PharmD, BCPS, BCCCP
    Guest: W. Frank Peacock, MD

    For patients with opioid-induced constipation (OIC), can Narcan play a role in finding a new treatment option? Dr. Charles Turck is joined by Dr. Frank Peacock from the Baylor College of Medicine to explore key data on the role of methylnaltrexone in the treatment of OIC.

    Recent Episodes from Clinician's Roundtable

    SUD Among Physicians: The Journey of Seeking Help and Treatments

    SUD Among Physicians: The Journey of Seeking Help and Treatments
    Host: Michael Greenberg, MD
    Guest: Chris Bundy, MD, MPH, FASAM

    Clinicians experiencing substance abuse disorder (SUD) may have some reluctance about utilizing a Physician Health Program; however, it’s important to know what your resources are in terms of formal treatment and to seek a psychiatrist with addiction specialization. Dive into part two of this discussion to learn more about the valuable resources and programs that can help physicians recover from SUD with Dr. Michael Greenberg and Dr. Chris Bundy, Executive Medical Director of the Washington Physicians Health Program and Clinical Assistant Professor of Psychiatry at the University of Washington School of Medicine.

    Unveiling the Numerous Benefits of RTA Prefilled Syringes

    Unveiling the Numerous Benefits of RTA Prefilled Syringes
    Host: Charles Turck, PharmD, BCPS, BCCCP
    Guest: John Hertig PharmD, MS, CPPS

    Here in the United States, we're investing a little more into cost effectiveness to make the best use of very limited healthcare resources. When ready-to-administer (RTA) syringe products were compared against traditional vial and syringe, there was a significant holistic cost effectiveness benefit. So what other benefits do we need to know about? Dive in with Dr. Charles Turck for a comprehensive review of RTA prefilled syringes with Dr. John Hertig, Vice Chair and Associate Professor of Pharmacy Practice at Butler University College of Pharmacy and Health Sciences in Indianapolis.

    Improving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware

    Improving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware
    Host: Ashley Baker, MSN, PMHNP
    Guest: Chi D. Chu, MD, MAS

    The National Health and Nutrition Examination Survey found that kidney disease awareness among patients in the U.S. is very low. And alarmingly, the proportion of awareness has not changed much over the 15-year period of this study. To uncover more of the findings and how to improve CKD awareness, tune into this discussion with Psychiatric Nurse Practitioner Ashley Baker as she takes a deep dive with Dr. Chi D. Chu, Assistant Professor of Medicine in the Division of Nephrology at the University of California San Francisco and coauthor of the article published in the American Journal of Kidney Diseases, titled “CKD Awareness Among US Adults by Future Risk of Kidney Failure.

    Uncovering the Prevalence of Mental Health and SUD Among Physicians

    Uncovering the Prevalence of Mental Health and SUD Among Physicians
    Host: Michael Greenberg, MD
    Guest: Chris Bundy, MD, MPH, FASAM

    Along with the general population, physicians are vulnerable to substance use disorder (SUD) with rates as high as 10 to 14 percent. And with demanding careers, stress and burnout can often exacerbate SUD. Tune into part one of this discussion with Dr. Michael Greenberg as he takes a deep dive into the prevalence of SUD and use characteristics among physicians with Dr. Chris Bundy, Executive Medical Director of the Washington Physicians Health Program and Clinical Assistant Professor of Psychiatry at the University of Washington School of Medicine.

    Read the original publication, titled "The Whole Physician: Physicians with Substance Use Disorder: Help is Available," which was published on Practical Neurology in November 2023.

    The Positive Impacts of AI to Promote Exercise in Asthma Patients

    The Positive Impacts of AI to Promote Exercise in Asthma Patients
    Host: Charles Turck, PharmD, BCPS, BCCCP
    Guest: Basil M. Kahwash, MD

    Patients with asthma who have experienced challenges with exercise may find that they are hesitant to exercise again in the future, or they may think it’s not safe to pursue. However, artificial intelligence (AI) may be a useful tool in promoting exercise in asthma patients due to its ability to generate a personalized approach for the patient with a quick turnaround. Explore the benefits between AI and exercise in asthma patients with Dr. Basil Kahwash, Assistant Professor of Medicine on the Clinical Educator Track in the Department of Medicine at Vanderbilt University in Nashville, Tennessee. He also spoke about this topic at the 2023 Annual ANAC conference in his session, titled “Managing Co-Occurring Conditions: A Clinical Update.”

    Exploring the Use of Peptide-Based Formulas in Enteral Nutrition Therapy

    Exploring the Use of Peptide-Based Formulas in Enteral Nutrition Therapy
    Host: Jennifer Caudle, DO
    Guest: Manpreet Mundi, MD

    Enteral nutrition intolerance is quite prevalent as it can be seen in up to 40 percent of patients who are tube fed. Due to the significant consequences of intolerance, there’s an urgency to manage patients symptoms, and one option that’s been shown to help is peptide-based tube feeding formulas. Joining Dr. Jennifer Caudle to talk about the management of enteral feeding intolerance with peptide-based tube feeding formulas is Dr. Manpreet Mundi, Professor of Medicine in the Department of Endocrinology at the Mayo Clinic College of Medicine and Science in Rochester, Minnesota.

    All trademarks are owned by Société des Produits Nestlé S.A., Vevey, Switzerland. ©2023 Nestlé

    Reviewing Individualized Therapy in CIDP Patients

    Reviewing Individualized Therapy in CIDP Patients
    Guest: Michael T. Pulley, MD PhD
    The chronic inflammatory demyelinating polyneuropathy (CIDP) treatment objective for disease stabilization and long-term maintenance is to get the patient to a normal functioning state with as few fluctuations and relapses as possible. Dive in with Dr. Qihua Fan, Assistant Professor in the Department of Neurology at Virginia Commonwealth University.

    Epoprostenol: A Look at a Last-Line Inhalation Therapy for ARDS

    Epoprostenol: A Look at a Last-Line Inhalation Therapy for ARDS
    Host: Charles Turck, PharmD, BCPS, BCCCP
    Guest: Justin Reinert, PharmD

    Acute respiratory distress syndrome (ARDS) is a severe lung condition characterized by the rapid onset of widespread inflammation in the lungs, but inhaled epoprostenol can be used as a last-line treatment strategy for these patients. Learn more about this treatment option’s efficacy and safety with Dr. Charles Turck and Dr. Justin Reinert, Assistant Professor of Clinical Pharmacy at the University of Toledo.

    Insights on the Benefits of Exercise in Asthma Patients

    Insights on the Benefits of Exercise in Asthma Patients
    Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
    Guest: Basil M. Kahwash, MD

    Patients with asthma could benefit greatly from exercising, and over time, it could lead to better asthma control. Dive into this episode to learn more about the findings from a recent study on exercise and asthma with Dr. Mary Katherine Cheeley and Dr. Basil Kahwash, Assistant Professor of Medicine on the Clinical Educator track in the Division of Allergy, Pulmonary, and Critical Care Medicine at Vanderbilt University in Nashville, Tennessee.

    Diving into the Details of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis

    Diving into the Details of Bile Acids, Lipids, and Nucleotides in Psoriatic Arthritis
    Host: Charles Turck, PharmD, BCPS, BCCCP
    Guest: Ananta Paine, PhD

    The diagnosis of psoriatic arthritis has not been easy due to the lack of knowledge about an established biomarker. To learn more, join Dr. Charles Turck as he speaks with Dr. Ananta Piane, Principal Investigator and Research Assistant Professor at the University of Rochester Medical Center in Rochester, New York, to discuss his 500-patient cohort study to find out if there are underlying differences of psoriasis patients who did not convert to psoriatic arthritis with those who did.

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io